Racial health disparities in the United States
Disparities between Black and White Americans in health care coverage and health outcomes are pervasive in the United States.
Research
Willingness-To-Pay vs Administrative Hurdles: Understanding Barriers to Social Insurance Enrollment in Thailand
Many government social insurance policies have low take-up.
Health Equity in the 2024 U.S. Presidential Election
The next U.S. president will inherit multiple epidemics with inequitably distributed effects. Kamala Harris and Donald Trump are likely to take divergent policy approaches to addressing these crises.
Medicare Part D Protected-Class Policy Is Associated With Lower Drug Rebates
Medicare Part D does not allow plans to exclude drugs in six protected classes from their formularies, which may limit plans’ ability to negotiate rebates and lead to higher spending.
Review of The Resilient Society
The Resilient Society by Markus Brunnermeier is a creative, wide-ranging book that aims and often succeeds at providing a new perspective on a broad variety of policy issues facing both advanced and e
Skills and Human Capital in the Labor Market
This paper synthesizes the economics literature on skills and human capital, with a particular focus on higher-order capacities like social and decision-making skills.
The Rapid Adoption of Generative AI
Generative Artificial Intelligence (AI) is a potentially important new technology, but its impact on the economy depends on the speed and intensity of adoption.
This Is What Thriving Communities Look Like: Insights from Residents of Four Boston Neighborhoods
In the summer of 2020, George Floyd’s video-graphed murder by Minneapolis police officers sparked a renewed public discourse about the role that police and policing play in the United States.
Thinking about Parents: Gender and Field of Study
In this paper, we implement a lab-in-field experiment among around 2000 children enrolled in 14 middle schools in Italy to investigate whether thinking about parental recommendation affects students’
Biopharma Venture Capital And The Inflation Reduction Act
The Inflation Reduction Act (IRA) of 2022 is the most significant reform to US prescription drug pricing in two decades and the first expected to result in a net reduction in Medicare drug costs.
Get smart & reliable public policy insights right in your inbox.